Capsule Summary Slidesets

Share

Program Content

Activities

  • Protocol 011 Week 96 Safety Analysis
    Phase IIb Protocol 011 Safety Analysis at Week 96: Islatravir Plus Doravirine Following Islatravir, Doravirine, Lamivudine Induction
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 20, 2021

    Expires: July 19, 2022

  • FLAIR
    FLAIR: Week 124 Results of Long-Acting Injectable Cabotegravir + Rilpivirine
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 21, 2021

    Expires: July 20, 2022

  • CUSTOMIZE
    CUSTOMIZE: Implementation-Effectiveness Study of Long-Acting Cabotegravir and Rilpivirine Injection in US Healthcare Settings
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 22, 2021

    Expires: July 21, 2022

  • TANGO Post-Hoc Analysis
    TANGO: Post-Hoc Analysis of Viral Replication for 2-Drug DTG/3TC Regimen vs 3- or 4-Drug TAF-Based Regimen Through Week 96
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 22, 2021

    Expires: July 21, 2022

  • DTG in CALHIV
    Outcomes of Dolutegravir Use in Children and Adolescents Living With HIV-1 in Sub-Saharan Africa
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 22, 2021

    Expires: July 21, 2022

  • CAPELLA
    CAPELLA: Week 26 Results of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced Patients
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 22, 2021

    Expires: July 21, 2022

  • CALIBRATE Interim Results
    CALIBRATE: Interim Week 28 Results of Long-acting Subcutaneous Lenacapavir in Treatment-Naive Patients
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 24, 2021

    Expires: July 23, 2022

  • REACH
    REACH: Adherence to Dapivirine Vaginal Ring and Oral PrEP Among Adolescent Girls and Young Women in Africa
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 24, 2021

    Expires: July 23, 2022

  • GEMS: PrEP and Resistance
    GEMS: ART Resistance in Persons Diagnosed With HIV After PrEP Rollout in Sub-Saharan Africa
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 24, 2021

    Expires: July 23, 2022

  • ZeNix
    ZeNix: Pretomanid, Bedaquiline, and Varied Doses and Durations of Linezolid in Highly Resistant TB
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 26, 2021

    Expires: July 25, 2022

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner